The use of trimodality therapy for the treatment of operable esophageal carcinoma in the veteran population: Patient survival and outcome analysis

Cancer

Volumn 92, Issue 5, 2001, Pages 1272-1280

  Caseycunningham, C ^a,b,d   Holmlund, Jon T ^c   Geary, Richard S ^c   Jessekwoh, T ^c   Dorr, Andrew ^c   Johnston, Joseph F ^c   Monia, Brett ^c   Nemunaitis, John ^a,b  

^a Developmental Therapeutics Committee and Co Chair of the Genitourinary Committee   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c ISIS PHARMACEUTICALS   (United States)

^d Collins Building ^*  (United States)

Author keywords

Chemotherapy; Esophageal neoplasms; Radiation therapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SOLDIER; TREATMENT OUTCOME;

AGED; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035447435     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010901)92:5<1272::AID-CNCR1448>3.0.CO;2-A     Document Type: Article

References (22)

1. Cancer statistics, 2000
2. Cancer statistics by race and ethnicity
3. Low dose preoperative radiotherapy for carcinoma of the oesophagus: Results of a randomized clinical trial
4. The value of preoperative radiotherapy in esophageal cancer: Results of a study of the E.O.R.T.C
5. Preoperative radiotherapy for carcinoma of the esophagus
6. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial
7. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer
8. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus
9. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
10. A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal adenocarcinoma: Updated analysis
11. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus
12. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
13. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus
14. Neoadjuvant paclitaxel, cisplatin and radiation for esophageal cancer
15. Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: Preliminary results of phase II trial
16. Neoadjuvant paclitaxel/carboplatin/5-FU/radiation therapy for localized esophageal cancer: Update of a Minnie Pearl Cancer Research Network Phase II Trial
17. Mortality ascertainment in the veteran population: Alternatives to the National Death Index
18. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
19. Effective surgical adjuvant therapy for high-risk rectal carcinoma
20. Outcome of patients receiving radiation for cancer of the esophagus: Results of the 1992-1994 Patterns of Care Study